France· FR:65933346
IASOdopa 0,3 GBq/mL, solution injectable
A medicinal product containing 6-fluoro-[18f]-l-dihydroxyphénylalanine, registered in France by CURIUM AUSTRIA (AUTRICHE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- 6-FLUORO-[18F]-L-DIHYDROXYPHÉNYLALANINE
- Manufacturer
- CURIUM AUSTRIA (AUTRICHE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009566897811 flacon(s) en verre de 25 ml
- cip1334009578256211 flacon(s) en verre de 15 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfdbc0cf-04b6-488f-a990-f131f54e8ec9 GET /v1/drugs/cfdbc0cf-04b6-488f-a990-f131f54e8ec9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65933346",
"date_amm": "2006-11-16",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "6-FLUORO-[18F]-L-DIHYDROXYPHÉNYLALANINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about 6-fluoro-[18f]-l-dihydroxyphénylalanine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.